WOBURN, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK) today reported financial results for the third quarter ended September 30, 2007. The Company also announced that it is in negotiations to terminate its license and supply agreements entered into with Galderma Pharma in June 2006 for the ELEVESS family of products.
